Pharmaceutical Technology3h
FDA approves Gomekli as first neurofibromatosis drug for adults
The US Food and Drug Administration (FDA) has approved SpringWorks Therapeutics’ Gomekli (mirdametinib) to treat ...
Pharmaceutical Technology3h
EC grants marketing authorisation to BridgeBio’s ATTR-CM treatment
EC has granted marketing authorisation to BridgeBio Pharma’s acoramidis under the Beyonttra brand name for treating ATTR-CM.
Pharmaceutical Technology3h
Travere takes rare disease kidney drug to FDA despite failed trial
Travere’s stock price climbed by 14% following the announcement it will seek an FDA label expansion for Filspari.
Pharmaceutical Technology6h
Health Canada approves MSD’s Keytruda for NSCLC stages
Health Canada has approved MSD’s anti-programmed cell death protein 1 (PD-1) therapy Keytruda for treating adults with ...
Pharmaceutical Technology21h
UK awards £82.6m to AI drug discovery companies
The UK announced the funding at the AI Action Summit in Paris where it abstained from signing a declaration on an inclusive ...
Pharmaceutical Technology22h
WHO and St Jude start distributing paediatric cancer medicines amid US aid cuts
The World Health Organization and St Jude Children's Research Hospital have kicked off a programme to distribute cancer ...
Pharmaceutical Technology17h
Be realistic, responsive and transparent: how to engage underperforming sites
Being realistic, responsive and transparent is key in engaging unresponsive and underperforming clinical trial sites; that ...